ALX ONCOLOGY HOLDINGS INC.

(ALXO)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
11.47 USD   +5.62%
08/01ALX Oncology Receives FDA Fast-Track Designation for Head, Neck Cancer Drug
MT
08/01ALX Oncology's Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma
GL
08/01ALX Oncology's Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ALX ONCOLOGY HOLDINGS INC.
Upcoming events on ALX ONCOLOGY HOLDINGS INC.
09/01/22 Interim 2022 Earnings Release (Projected)
11/17/22 Q3 2022 Earnings Release (Projected)
03/16/23 FY 2022 Earnings Release (Projected)
05/15/23 Q1 2023 Earnings Release (Projected)
Past events on ALX ONCOLOGY HOLDINGS INC.
06/14/22 | 04:00pm Annual General Meeting
06/08/22 | 10:00am Jefferies Healthcare Conference
05/09/22 | 04:01pm Q1 2022 Earnings Release
02/28/22 | 07:00am FY 2021 Earnings Release
01/11/22 | 10:30am JP Morgan Healthcare Conference
12/13/21 | 08:00am American Society of Hematology Virtual Meeting and Exposition
12/12/21 | 06:00pm American Society of Hematology Virtual Meeting and Exposition - Poster Numbers - 637
11/22/21 | 10:00am Piper Sandler Virtual Healthcare Conference
11/18/21 | 03:00am Jefferies London Healthcare Conference
11/16/21 | 10:00am Stifel Healthcare Conference
Past dividends on ALX ONCOLOGY HOLDINGS INC.

- No events available -

Annual results
Fiscal Period : December2019202020212022
Sales
M $
Released
Forecast
Spread
4,80

 
1,18
1,11
6,2%


 
 

 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-43,5
-37,8
-15%
-83,5
-80,2
-4,1%
 
-110
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-43,7
-38,0
-15%
-83,6
-80,6
-3,7%
 
-111
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-45,5
-39,4
-16%
-83,5
-79,9
-4,5%
 
-108
 
Net income
M $
Released
Forecast
Spread


 
-45,7
-41,9
-9,3%
-83,5
-79,9
-4,5%
 
-110
 
EPS
$
Released
Forecast
Spread
-1,15

 
-2,76
-1,87
-48%
-2,07
-1,97
-5,2%
 
-2,70
 
Announcement Date05/05/202003/18/202102/28/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread

0,16
 

0,13
 


 


 


 
 

 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 


 
 
-22,7
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-14,2
-17,3
18%
-16,3
-18,7
13%
-24,6
-20,9
-18%
-28,5
-26,7
-6,8%
-24,7
-31,0
20%
 
-26,1
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-14,2
-19,1
26%
-16,3
-17,4
6,6%
-24,6
-18,6
-32%
-28,5
-25,6
-11%
-24,5
-31,1
21%
 
-26,4
 
Net income
M $
Released
Forecast
Spread
-14,2
-19,1
26%
-16,3
-17,2
5,3%
-24,6
-19,1
-29%
-28,4
-25,6
-11%
-24,5
-31,0
21%
 
-26,7
 
EPS
$
Released
Forecast
Spread
-0,35
-0,44
20%
-0,40
-0,46
13%
-0,61
-0,51
-19%
-0,70
-0,62
-13%
-0,60
-0,71
16%
 
-0,63
 
Announcement Date05/17/202108/12/202111/11/202102/28/202205/09/2022-
Previous year Next Year
Upcoming sector events for ALX ONCOLOGY HOLDINGS INC.
More events
Past sector events for ALX ONCOLOGY HOLDINGS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise